17-51153539-C-A
Variant names: 
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_000269.3(NME1):c.-128C>A variant causes a upstream gene change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: not found (cov: 33) 
 Exomes 𝑓:  0.0   (  0   hom.  ) 
 Failed GnomAD Quality Control 
Consequence
 NME1
NM_000269.3 upstream_gene
NM_000269.3 upstream_gene
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  -0.0490  
Publications
30 publications found 
Genes affected
 NME1  (HGNC:7849):  (NME/NM23 nucleoside diphosphate kinase 1) This gene (NME1) was identified because of its reduced mRNA transcript levels in highly metastatic cells. Nucleoside diphosphate kinase (NDK) exists as a hexamer composed of 'A' (encoded by this gene) and 'B' (encoded by NME2) isoforms. Mutations in this gene have been identified in aggressive neuroblastomas. Two transcript variants encoding different isoforms have been found for this gene. Co-transcription of this gene and the neighboring downstream gene (NME2) generates naturally-occurring transcripts (NME1-NME2), which encodes a fusion protein comprised of sequence sharing identity with each individual gene product. [provided by RefSeq, Jul 2008] 
 NME1-NME2  (HGNC:33531):  (NME1-NME2 readthrough) This locus represents naturally occurring read-through transcription between the neighboring NME1 and NME2 genes. The significance of this read-through transcription and the function of the resulting protein product have not yet been determined. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Nov 2010] 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage; 
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.06). 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| NME1 | NM_000269.3  | c.-128C>A | upstream_gene_variant | ENST00000393196.8 | NP_000260.1 | |||
| NME1-NME2 | NM_001018136.3  | c.-128C>A | upstream_gene_variant | NP_001018146.1 | ||||
| NME1 | NM_198175.1  | c.-273C>A | upstream_gene_variant | NP_937818.1 | ||||
| NME1-NME2 | NR_037149.2  | n.-20C>A | upstream_gene_variant | 
Ensembl
Frequencies
GnomAD3 genomes  Cov.: 33 
GnomAD3 genomes 
Cov.: 
33
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF:  0.00  AC: 0AN: 68Hom.:  0  Cov.: 0 AF XY:  0.00  AC XY: 0AN XY: 42 
GnomAD4 exome 
Data not reliable, filtered out with message: AC0
 AF: 
AC: 
0
AN: 
68
Hom.: 
Cov.: 
0
 AF XY: 
AC XY: 
0
AN XY: 
42
African (AFR) 
AC: 
0
AN: 
0
American (AMR) 
AC: 
0
AN: 
0
Ashkenazi Jewish (ASJ) 
AC: 
0
AN: 
0
East Asian (EAS) 
AC: 
0
AN: 
0
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
32
Middle Eastern (MID) 
AC: 
0
AN: 
0
European-Non Finnish (NFE) 
 AF: 
AC: 
0
AN: 
28
Other (OTH) 
 AF: 
AC: 
0
AN: 
4
GnomAD4 genome  Cov.: 33 
GnomAD4 genome 
Cov.: 
33
Alfa 
 AF: 
Hom.: 
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.